rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Medicus Pharma Ltd.

MDCX · Nasdaq

Health CareBiotechnologyNot moving yet

MDCX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 79.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
21 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$558K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders21+3 on the quarter
New · exited9 · 6
Reported value$1.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Interchange Capital Partners, LLCreduced · filed 20 Jul 20261,586,871$718K-75,000−4.5%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026333,673$149K+333,673
XTX Topco Ltdnew · filed 14 Aug 2026243,362$109K+243,362
Sterling Investment Advisors, Ltd.new · filed 28 Jul 2026100,000$45K+100,000
COMMONWEALTH EQUITY SERVICES, LLCadded · filed 29 Jul 202652,643$23K+4,500+9.3%
May Hill Capital, LLCunchanged · filed 7 Aug 202650,622$23K00.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 202631,462$14K+31,462
STIFEL FINANCIAL CORPnew · filed 12 Aug 202630,000$13K+30,000
JPMORGAN CHASE & COnew · filed 12 Aug 202625,622$12K+25,622
Wilmington Savings Fund Society, FSBreduced · filed 28 Jul 202625,622$11K-25,622−50.0%
31 Dec 2024 – 30 Jun 2026
41220Dec 24Jun 25Sep 25Mar 26Jun 26

News

Everyone who traded it

Andrew Alasdair Smith Company insiderChief Operating Officer · last 4 Sep 20260 · 0
Carolyn F. Bonner Company insiderPresident and CFO · last 4 Sep 20260 · 0
Edward J. Brennan Company insiderChief Scientific Officer · last 4 Sep 20260 · 0
Faisal Mehmud Company insiderChief Medical Officer · last 4 Sep 20260 · 0
Raza Bokhari Company insiderChief Executive Officer · last 4 Sep 20260 · 0
Ajay Raju Company insiderDirector · last 3 Jun 20260 · 0
Barry Fishman Company insiderDirector · last 3 Jun 20260 · 0
Cathy McMorris Rodgers Company insiderDirector · last 3 Jun 20260 · 0
Larry Kaiser Company insiderDirector · last 3 Jun 20260 · 0
Patrick J. Mahaffy Company insiderDirector · last 3 Jun 20260 · 0
Robert J. Ciaruffoli Company insiderDirector · last 3 Jun 20260 · 0
Sara R. May Company insiderDirector · last 3 Jun 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Interest coverFY 2025 · to 31 Dec 2025174.08×
Share count trendFY 2025 · to 17 Mar 202656.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$8.7M

Analyst forecasts

No analyst forecasts yet.